AngioDynamics, Inc. - Income Statement (TTM)

AngioDynamics, Inc.
US ˙ NasdaqGS ˙ US03475V1017

Income Statement (TTM)

AngioDynamics, Inc. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.

All numbers are times 1,000,000 except per share units.

2020
11-30
2021
02-28
2021
05-31
2021
08-31
2021
11-30
2022
02-28
2022
05-31
2022
08-31
2022
11-30
2023
02-28
2023
05-31
2023
08-31
2023
11-30
2024
02-29
2024
05-31
2024
08-31
2024
11-30
2025
02-28
2025
05-31
Revenue 271 272 291 298 303 306 316 321 328 335 339 336 330 324 304 293 286 283 292
Change (%) 0.52 6.79 2.32 1.85 0.92 3.32 1.44 2.23 2.06 1.22 -0.84 -1.89 -1.68 -6.20 -3.68 -2.13 -1.11 3.24
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 125 129 134 137 142 145 150 154 156 160 165 164 162 161 149 141 135 129 135
Change (%) 3.11 4.44 2.29 3.74 1.99 3.59 2.13 1.71 2.57 2.60 -0.37 -0.94 -0.55 -7.59 -5.26 -4.15 -4.56 4.23
% of Revenue 45.98 47.16 46.12 46.11 46.96 47.46 47.59 47.91 47.67 47.91 48.56 48.79 49.27 49.83 49.10 48.29 47.29 45.64 46.08
Gross Operating Profit 146 144 157 160 161 161 166 167 172 174 174 172 167 163 155 151 151 154 158
Change (%) -1.69 8.90 2.34 0.24 -0.03 3.07 0.82 2.71 1.59 -0.06 -1.29 -2.80 -2.78 -4.83 -2.16 -0.24 1.98 2.40
% of Revenue 54.02 52.84 53.88 53.89 53.04 52.54 52.41 52.09 52.33 52.09 51.44 51.21 50.73 50.17 50.90 51.71 52.71 54.36 53.92
SG&A 114 112 117 126 130 133 134 140 144 146 144 146 144 146 144 143 144 144 146
Change (%) -2.20 5.06 7.42 2.97 2.45 0.88 4.48 2.54 1.61 -0.98 1.10 -1.44 1.21 -1.02 -1.10 0.89 0.03 1.18
% of Revenue 42.09 40.95 40.28 42.29 42.75 43.40 42.38 43.65 43.78 43.59 42.64 43.48 43.68 44.96 47.44 48.71 50.21 50.79 49.78
R&D 33 34 36 34 33 32 30 32 31 30 30 29 31 32 31 30 27 26 26
Change (%) 0.49 8.17 -5.45 -3.98 -1.93 -5.92 4.88 -4.26 -3.04 0.05 -1.34 6.26 4.30 -3.53 -5.45 -7.68 -4.79 -0.68
% of Revenue 12.35 12.35 12.50 11.56 10.89 10.59 9.64 9.97 9.33 8.87 8.76 8.72 9.45 10.02 10.30 10.12 9.54 9.19 8.84
OpEx 291 292 306 316 323 329 334 345 350 355 357 357 354 354 338 326 318 310 317
Change (%) 0.27 4.68 3.16 2.47 1.85 1.52 3.20 1.37 1.50 0.65 -0.18 -0.86 0.21 -4.72 -3.61 -2.42 -2.56 2.26
% of Revenue 107.52 107.26 105.14 106.00 106.65 107.63 105.76 107.59 106.69 106.11 105.51 106.22 107.34 109.40 111.14 111.21 110.88 109.26 108.23
Operating Income -20 -20 -15 -18 -20 -23 -18 -24 -22 -20 -19 -21 -24 -30 -34 -33 -31 -26 -24
Change (%) -2.98 -24.36 19.42 12.83 15.82 -21.98 33.73 -9.88 -6.85 -8.66 11.89 15.79 25.89 11.08 -3.01 -5.00 -15.87 -8.28
% of Revenue -7.52 -7.26 -5.14 -6.00 -6.65 -7.63 -5.76 -7.59 -6.69 -6.11 -5.51 -6.22 -7.34 -9.40 -11.14 -11.21 -10.88 -9.26 -8.23
Interest Expense -1 -1 -1 -1 -1 -1 -1 -1 -1 -2 -3 -2 -2 -1
Change (%) -37.22 -5.49 -6.85 -7.61 -7.15 -0.00 32.70 55.86 39.56 36.05 -14.10 -29.47 -44.96
% of Revenue -0.54 -0.33 -0.30 -0.27 -0.24 -0.22 -0.22 -0.28 -0.43 -0.59 -0.80 -0.69 -0.50 -0.28
Net Income -171 -169 -32 -34 -38 -40 -27 -33 -33 -37 -52 6 -14 -192 -184 -243 -225 -41 -34
Change (%) -1.26 -81.35 8.57 11.92 3.69 -33.21 22.72 0.41 13.84 40.82 -112.29 -318.99 1,262.76 -4.17 31.83 -7.53 -81.58 -17.88
% of Revenue -63.19 -62.07 -10.84 -11.50 -12.64 -12.99 -8.40 -10.16 -9.98 -11.13 -15.48 1.92 -4.28 -59.37 -60.66 -83.02 -78.44 -14.61 -11.62

Source: Capital IQ

Other Listings
DE:UG2 €9.00
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista